Reporting Season Review
About the author:
- Author name:
- By Andrew Tang
- Job title:
- Analyst - Equity Strategy
- Date posted:
- 03 September 2019, 9:30 AM
- Sectors Covered:
- Equity Strategy and Quant
FY19 proved to be a difficult year for earnings, excluding Financials, Utilities, Resources and REITs, earnings contracted 3.0%. However, fewer significant misses from market stalwarts imply results were likely no worse than feared.
Investors were prepared to look forward and back companies that appear to be at an earnings inflection point. Some early trading updates confirm that a change in consumer and business confidence is underway despite the global uncertainty.
Our standout opportunities include Cleanaway, Sonic Healthcare, Treasury Wine Estates and Woodside.
Familiar dynamics at play as we enter FY20
Aussie Industrial companies (ASX200 ex-Resources) grew their profits by only 1.0% in FY19 reflecting the challenging economy and a remedial year by the major banks (EPS down ~6%).
Important portfolio stocks reported robust results (Commonwealth Bank (CBA), Wesfarmers (WES), Woolworths (WOW), Telstra (TLS), Transurban (TCL)), however more than usual delivered 'misses' on their FY20 outlooks.
We'd flagged that expectations for FY20 looked far too heroic heading into August, so it wasn't surprising that forecast FY20 EPS growth (again ex-Resources) has eroded from 8.3% prior, to 6.2% currently.
We're cautious about ongoing erosion in the context of dividend sustainability (supporting the 'equity yield arbitrage' trade) and upward pressure on stretched valuations which leave little room for error.
Green shoots domestically trump offshore earners
Global economic uncertainty continues to weigh on the ASX's offshore earners. They were one of the few bright spots for the market in recent years but the prolonged trade war and slowdown in Chinese growth is putting a dent in the earnings outlook.
The median FY20 revision in some of the key names (Brambles (BXB): -15%, Orora (ORA): -8%, Amcor (AMC), -6%, Corporate Travel (CTD): -9%) reflects the challenges ahead.
Domestically, early trading updates confirm that a stabilisation in housing, tax cuts and lower interest rates are working their way through the economy.
We see better value looking local Cleanaway (CWY), Westpac (WBC), Wesfarmers (WES) and People Infrastructure (PPE).
Other interesting themes from August
Retailers enjoyed a good bounce on evidence of a consumer turnaround, helped by undemanding valuations.
Expensive Online stocks popped (Seek (SEK), REA Group (REA), Domain Holdings (DHG)) despite EPS downgrades, driving PE expansion to ~33x which we're still struggling to rationalise (late cycle exuberance anyone?).
Buybacks and Specials featured heavily (+$2bn in new buybacks from Qantas (QAN), AGL Energy (AGL), Amcor (AMC), Link Administration Holdings (LNK)), but our growth starved market now prefers to reward those willing to invest, rather than return capital.
High Growth/PE saw some profit taking as several key names missed investors' lofty expectations (Appen Limited (APX), Nearmap (NEA), Breville Group (BRG), A2 Milk (A2M), Bellamy's (BAL), Blackmores (BKL)), perhaps a sign that the 'growth at any cost' trade may be nearing a reversal.
Compelling ideas are still out there
We continue to identify compelling value in select companies, amongst a broader market which looks expensive, and profile our updated preferred picks in our full research note. Standout opportunities include Cleanaway, Sonic Healthcare, Treasury Wine Estates and Woodside.
To view further analysis on the August 2019 reporting season, Morgans clients can view the full research note. Alternatively, please contact your Morgans adviser or nearest Morgans office for access.
Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.